NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/07/2026
Voltar para busca
Dado oficial do USPTO
C
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
16/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 35, 42
Data de depósito
02/04/2021
Data de registro
02/08/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/08/2022
Última transação
16/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
IT
Examinador
WELLS, KELLEY L
Unidade examinadora
M90
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists a hexagon shape consisting on the left side of a letter "C" in pantone cool gray 4 C and on the right side of the stylized representation of an anchor formed by a circle and a right pointing arrow in fuchsia pantone 227 C.
Titulares e representantes
Titulares
CHIESI FARMACEUTICI S.P.A.
Representantes
Reed Fryar Vorys, Sater, Seymour and Pease LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticals for the treatment of diseases of the respiratory systemcentral nervous system CNSthe metabolic systemthe cardio-vascular systemthe musculo-skeletal systemimmune systemgastro-intestinal systemendocrine systemcaused by bacteria; Pharmaceuticals for the treatment of autoimmune disordersviral diseasesskin diseases; pharmaceuticals and natural remedies for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; pharmaceutical compositions for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; chemico-pharmaceutical preparations for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; medicines for human purposes for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; medicinal healthcare preparations for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; medicinal preparations and substances for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; biotechnological preparations for medical use for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; stem cells for medical purposes; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating respiratory diseases; medicinal infusions for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; medicated compresses; preparations for detecting genetic predispositions for medical purposes; pharmaceutical preparations for the treatment of central nervous system CNS diseases; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the prevention of diseases of the cardio-vascular system; pharmaceutical preparations for the treatment of diseases of the musculo-skeletal system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the treatment of disorders caused by bacteria; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations for ophthalmological use; pharmaceutical products for ophthalmological use; medicated plasters; transdermal patches for the treatment of diseases of the musculo-skeletal system; transdermal patches for medical treatment of the musculo-skeletal system diseases; liquid vitamin supplements; nutritional supplements; nutraceutical preparations for therapeutic or medical purposes for the treatment cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; nutraceuticals for use as a dietary supplement; vitamin preparations in the nature of food supplements; dietary supplements consisting of vitamins; nutraceuticals for therapeutic purposes for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; enzyme dietary supplements; vitamin and mineral supplements; disinfectants and antiseptics; viral vaccines
Classe 10
medical apparatus and instruments for treating cardiovascular diseasefor treating osteoarthritisfor monitoring blood oxygen saturationblood gas concentrationsvital signs and respiratory events; apparatus for administering pharmaceuticalsmedical devices for accessing subcutaneous structures of the human body; apparatus for administering drugs by inhalation sold empty; medical ventilators; oxygen inhalators for therapeutic purposes sold empty; infusion pumps to deliver medication; respiratory therapy instrumentssterile disposable oxygen humidifiers and nebulizers for respiratory therapy sold pre-filled with water; medical apparatus for assisting breathingportable devices used for breathing exercises and for respiratory muscle training; portable nebulisers for medical purposes; ventilator breathing apparatus for artificial respiration; medical apparatus for the treatment of respiratory conditionsinfusion and injection devices for delivering pharmaceuticals and solutionsoxygen inhalatorsinfusion pumpsportable nebulisers for medical purposesall sold emptymedical apparatus for the treatment of respiratory conditionsinfusion and injection devices for delivering pharmaceuticals and solutionsoxygen inhalatorsinfusion pumpsportable nebulisers for medical purposesall sold empty; respiratory masks for medical purposes; inhalers for medical usesold empty; nebulizers for respiration therapy; respirators for artificial respiration for medical purposes; apparatus for the alleviation of breathing difficultiesinfusion and injection devices; masks and equipment for artificial respiration; oxygenators for medical use; medical apparatus for facilitating the inhalation of pharmaceutical preparationssold empty; vaporizers for the treatment of upper respiratory conditions; oxygen inhalers for medical use sold empty; diagnosticexamination and monitoring equipmentequipment for monitoring blood oxygen saturationblood gas concentrationsvital signs and respiratory events; surgical ophthalmic instruments; massage apparatus; dummies for babies; catheters for medical use; apparatus for the regeneration of stem cells for medical purposes; implantable subcutaneous drug delivery devices; prostheticsligaments and tissues for vascular use and artificial implant; artificial limbs; orthopedic articlesdevices used in orthopedic transplant and/or implant surgery; orthopedic joint implants made of artificial materials; sphygmotensiometers; equipment for diagnosisexaminations and monitoringequipment for monitoring blood oxygen saturationblood gas concentrationsvital signs and respiratory events
Classe 35
Promotional and advertising services; advertising services relating to pharmaceutical products; advertising services to promote public awareness of medical issues; advertising services to promote public awareness of medical conditions; advertising services relating to cosmetics; providing consumer product information relating to cosmetics; retail store services in relation to dietetic preparations; retail store services in relation to pharmaceutical preparations; online retail store services in relation to cosmetics; retail store services in relation to medical instruments; retail store services in relation to medical apparatus; retail store services for a pharmaceuticalveterinary and sanitary preparations and medical supplies
Classe 42
Scientific and technology servicespharmaceutical drug development services; technological research services in the field of pharmaceutical research and development; scientific research in the field of pharmacy; scientific research relating to biology; scientific research relating to genetics; scientific research and industrial research in the field of pharmaceutical research and development; scientific research and analysispharmaceutical research and development; scientific and technological services relating to pharmaceutical drug and nutritional supplements development; medical and pharmacological research services; providing scientific information in the field of medical disorders and their treatment; development of pharmaceutical preparations and medicines; research and development in the pharmaceutical and biotechnology fields; bacteriological research and analysis; biological research and analysis; chemical research and analysis services; clinical researchconducting clinical trials for others; biological researchclinical research in the field of respiratory science and medicine and medical research; industrial analysis and research services in the field of pharmaceutical research; stem cell research; scientific services relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/12/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
17/11/2022
FIMP
FINAL DISPOSITION PROCESSED
16/11/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/11/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/05/2022
PUBO
PUBLISHED FOR OPPOSITION
17/05/2022
GPNX
NOTIFICATION PROCESSED BY IB
16/05/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/04/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/04/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
14/04/2022
ALIE
ASSIGNED TO LIE
12/04/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/04/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
11/04/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/04/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
11/04/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/03/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/03/2022
RFNT
REFUSAL PROCESSED BY IB
10/01/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/12/2021
RFRR
REFUSAL PROCESSED BY MPU
22/12/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/11/2021
CNRT
NON-FINAL ACTION WRITTEN
18/11/2021
DOCK
ASSIGNED TO EXAMINER
17/11/2021
MAFR
APPLICATION FILING RECEIPT MAILED
23/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/10/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
14/10/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace C ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.